<prompt> Please answer with one of the option in the bracket. Write reasoning in between . Write answer in between .Q:A 35-year-old woman is admitted to the medical unit for worsening renal failure. Prior to admission, she was seen by her rheumatologist for a follow-up visit and was found to have significant proteinuria and hematuria on urinalysis and an elevated serum creatinine. She reports feeling ill and has noticed blood in her urine. She was diagnosed with systemic lupus erythematosus at the age of 22, and she is currently being treated with ibuprofen for joint pain and prednisone for acute flare-ups. Her blood pressure is 165105 mmHg. Laboratory testing is remarkable for hypocomplementemia and an elevated anti-DNA antibody. A renal biopsy is performed, which demonstrates 65 glomerular involvement along with the affected glomeruli demonstrating endocapillary and extracapillary glomerulonephritis. In addition to glucocorticoid therapy, the medical team will add mycophenolate mofetil to her treatment regimen. Which of the following is the mechanism of action of mycophenolate mofetil?? A: Calcineurin inhibitor via cyclophilin binding, B: Calcineurin inhibitor via FKBP binding, C: Inosine monophosphate dehydrogenase inhibitor, D: Interleukin-2 receptor complex inhibitor, E: mTOR inhibitor via FKBP binding,  <response>: This is a multiple choice question asking about the mechanism of action of mycophenolate mofetil, an immunosuppressive drug used in systemic lupus erythematosus and other autoimmune conditions. The question stem provides a clinical vignette of a 35-year-old woman with worsening lupus nephritis who will be started on mycophenolate mofetil in addition to glucocorticoids. To answer this, I need to know the mechanism of action of mycophenolate mofetil. The answer choices provide different mechanisms of action for immunosuppressive drugs.C: Inosine monophosphate dehydrogenase inhibitor 